Mitochondria-Targeted Antioxidant SkQ1 Improves Dermal Wound Healing in Genetically Diabetic Mice

Ilya A Demyanenko1, Vlada V Zakharova2, Olga P Ilyinskaya1

  • 1Faculty of Biology, Lomonosov Moscow State University, Leninskie Gory 1-12, Moscow 119234, Russia.

Insights

Mitochondria-targeted antioxidant SkQ1 significantly improved wound healing in diabetic mice by enhancing tissue repair and normalizing inflammation. This suggests mitochondrial reactive oxygen species play a key role in delayed diabetic wound healing.

Area of Science:

  • Biomedical Science
  • Cell Biology
  • Diabetology

Background:

  • Oxidative stress and mitochondrial reactive oxygen species (ROS) are implicated in delayed wound healing in diabetes.
  • The specific role of mitochondrial ROS in diabetic wound repair remains largely unexplored.

Purpose of the Study:

  • To investigate the role of mitochondrial ROS in diabetic wound healing using a mitochondria-targeted antioxidant.
  • To evaluate the therapeutic potential of SkQ1 in accelerating wound closure and improving tissue regeneration in diabetic mice.

Main Methods:

  • Administration of SkQ1, a mitochondria-targeted antioxidant, to genetically diabetic mice (C57BL/KsJ-db-/db-) with full-thickness excisional dermal wounds.
  • Assessment of wound healing parameters including closure rate, epithelization, granulation tissue formation, and vascularization.
  • Analysis of cellular infiltration (myofibroblasts, neutrophils, macrophages), lipid peroxidation, and inflammatory cytokines (IL-6, TNF).
  • In vitro scratch-wound assay under hyperglycemic conditions to assess cell migration.

Main Results:

  • Long-term SkQ1 administration (12 weeks) significantly enhanced wound healing in diabetic mice.
  • SkQ1 accelerated wound closure, epithelization, granulation tissue formation, and vascularization.
  • Treatment modulated inflammatory cell infiltration, increased myofibroblasts, and reduced neutrophils while increasing macrophages.
  • SkQ1 lowered lipid peroxidation levels and improved cell migration in vitro under hyperglycemia.

Conclusions:

  • Mitochondria-targeted antioxidant SkQ1 effectively normalized both inflammatory and regenerative phases of wound healing in diabetic mice.
  • Excessive mitochondrial ROS production significantly impairs major steps of wound healing in type II diabetes.
  • SkQ1 demonstrates therapeutic potential for treating delayed wound healing in diabetic conditions.

Related Concept Videos